Evan Jones, M.B.A.

Evan Jones began serving as a member of Veracyte’s board of directors in 2008. Mr. Jones has achieved a distinguished career leading and investing in pioneering life sciences companies. He has served as Managing Member of jVen Capital, LLC, a life sciences investment company, since 2007. He previously served as Chief Executive Officer of OpGen Inc., a publicly held genetic analysis company, from 2013 to March 2020, and as a director from 2009 to 2020. Mr. Jones co-founded Digene Corporation, a publicly traded molecular diagnostics company focused on women’s health, serving as Chairman of the Board from 1995 until its acquisition in 2007 and as Chief Executive Officer from 1990 to 2006. He is a member of the board of directors for Protagene GmbH, a leading provider of analytical services for biologicals and cell and gene therapy development. He previously served as a member of the board of directors of Foundation Medicine, Inc., Fluidigm Corporation and CAS Medical Systems, Inc. Mr. Jones received a B.A. in Biotechnology from the University of Colorado and an M.B.A. from The Wharton School at the University of Pennsylvania.